| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 30.5MM | +0% |
| Gross Profit | 7.7MM | +8% |
| Cost Of Revenue | 22.8MM | -2% |
| Operating Income | -37.4MM | -18% |
| Operating Expenses | 45.1MM | -14% |
| Net Income | -38.6MM | -16% |
| R&D | 12.5MM | -22% |
| G&A | 10.3MM | -12% |
| Marketing | 22.2MM | -10% |
| Interest Expense | 3.4MM | +6% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Outset Medical's (OM) latest agreement is likely to provide patients and caregivers access to innovative home dialysis with the Tablo Hemodialysis System.
SAN JOSE, Calif., April 17, 2024--Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, and U.S. Renal Care, the largest privately held kidney care provider in the United States, announced today a multi-year agreement to help accelerate home hemodialysis in the U.S.
SAN JOSE, Calif., April 15, 2024--Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced its partnership with the American Nephrology Nurses Association (ANNA) as a member of its new Partnership Advisory Council. This collaboration underscores Outset’s dedication to supporting the nephrology nursing community and improving patient care in the realm of kidney disease.
SAN JOSE, Calif., March 13, 2024--Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of medical technology veteran Brent D. Lang to its board of directors. Mr. Lang most recently served as Chairman and Chief Executive Officer of Vocera Communications, a global provider of clinical communication and workflow solutions, until its acquisition by Stryker fo
Investors’ focus on the potential for Ozempic to disrupt various industries was on full display Tuesday. The industry in question this time: dialysis. Shares of companies providing dialysis services to kidney-disease patients, including Fresenius, DaVita and Outset Medical, were all up—Fresenius by some 11%—after drugmaker Novo Nordisk released [new details from a study of Ozempic](https://www.
SAN JOSE, Calif., February 26, 2024--Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 44th annual TD Cowen Health Care conference on Tuesday, March 5, 2024, at 1:30 p.m. Eastern time.
Outset Medical ( NASDAQ:OM ) Full Year 2023 Results Key Financial Results Revenue: US$130.4m (up 13% from FY 2022). Net...
Outset Medical, Inc. (NASDAQ:OM) Q4 2023 Earnings Call Transcript February 21, 2024 Outset Medical, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by, and welcome to the Outset Medical Fourth Quarter 2023 Earnings Conference Call. […]
Q4 2023 Outset Medical Inc Earnings Call
Revenue Growth and Margin Expansion Amidst Net Loss Reduction